Theralink Technologies

About:

Theralink Technologies is a molecular company specializing in patented, biomarker assay services that target multiple areas of oncology.

Website: https://theralink.com

Description:

Theralink Technologies is a molecular company specializing in patented, biomarker assay services that target multiple areas of oncology. Their research indicates that genomic and transcriptomic information alone provides an incomplete information resource for physicians to make patient-specific treatment decisions. The company was founded in 2005 and is headquartered in Baton Rouge, Louisiana.

Total Funding Amount:

$4.19M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Golden, Colorado, United States

Founded Date:

2005-01-01

Contact Email:

info(AT)theralink.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2022-11-29

IPO Status:

Public

Industries:

© 2025 bioDAO.ai